CCNE1 and cancer: Cyclin E gene amplification [90], overexpression of cyclin E mRNA or protein levels [88,91], decrease of cyclin E turnover [92], together with the presence of more active forms of cyclin E [93,94,95], have been reported in many types of cancers, such as breast, gastrointestinal, lung, and skin cancers.